AWARDEE:

TANTU THERAPEUTICS

A living therapeutic patch to heal damaged gut lining

ENTREPRENEUR:

Anna Duraj–Thatte, PhD

INDUSTRY: 

Life Sciences

AMOUNT AWARDED: $50,000

ABOUT TANTU THERAPEUTICS:

Tantu Therapeutics is developing innovative microbe-based therapeutics expressed and delivered to the site of intestinal lesions to treat Inflammatory Bowel Disease (IBDJ and other gastrointestinal (GI) diseases without systemic side effects.

VALUE PROPOSITION

1.6 million Americans suffer from debilitating and poorly treated IBD diseases. Existing treatment do not achieve mucosal healing and 1/3 of patients still require surgery.

Tantu Therapeutics will provide an orally administered, live inflammatory factors directly into the diseased sites, resulting in improved gut barrier function and faster mucosal healing as well as extend remission to avoid the surgery in most patients.

PROJECT LEADERSHIP

Anna Duraj-Thatte, PhD
Co-founder and Scientific Lead

John Tagliamonte, MBA
Co-founder and Business Lead

Neel Joshi, PhD
Co-founder and Scientific Advisor

MEET THE Spring 2021 Spark Fund Recipients